This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
The CTS 2020 Annual Laboratory Survey is on its way to your email box. We would appreciate you takin...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
On December 28, 2021, the FDA updated the emergency use authorization (EUA) for COVID-19 conva...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...